These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 2147029

  • 1. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
    Winer N, Kirkendall WM, Canosa FL, Lewin AJ, McMahon FG, Carr AA, Cohen M.
    J Clin Pharmacol; 1990 Nov; 30(11):1006-11. PubMed ID: 2147029
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N, Thys-Jacobs S, Kumar R, Davidson WD, Grayson M, Harris C, Walker D, Itskovitz H, Gonasun L.
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of isradipine in hypertension.
    Shepherd AM, Carr AA, Davidov M, Hamilton J, Schnaper H, Velasquez M, Brockway B, Prisant LM, Hamilton B, Gonasun L.
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [Abstract] [Full Text] [Related]

  • 4. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM, Carr AA, Nelson EB, Winer N, Velasquez MT, Gonasun LM.
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [Abstract] [Full Text] [Related]

  • 5. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
    Holtzman JL, Abrams A, Cutler R, Hamilton B, Kirkendall WM, Neri G, Stein GH, Matthews KP.
    Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
    [Abstract] [Full Text] [Related]

  • 6. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP, Reyes AJ, Maharaj B, van der Byl K.
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr 17; 86(4A):110-4. PubMed ID: 2523644
    [Abstract] [Full Text] [Related]

  • 8. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S, Tantbirojn P, Koanantakul B, Nontakanun S, Jaroonvesama N, Charoenlarp K.
    Drugs; 1990 Apr 17; 40 Suppl 2():22-5. PubMed ID: 2150635
    [Abstract] [Full Text] [Related]

  • 9. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R, Svensson A, Dahlöf B, Hansson L.
    Am J Med; 1989 Apr 17; 86(4A):124-6. PubMed ID: 2523647
    [Abstract] [Full Text] [Related]

  • 10. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G, Aström B, Dahlöf B, Hansson L, Tollin C, Himanen P, Sundstedt CD.
    Am J Med; 1989 Apr 17; 86(4A):115-8. PubMed ID: 2523645
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure.
    Lacourcière Y, Poirier L, Dion D, Provencher P.
    Am J Cardiol; 1990 Feb 15; 65(7):467-72. PubMed ID: 2137666
    [Abstract] [Full Text] [Related]

  • 12. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
    Sundstedt CD, Rüegg PC, Keller A, Waite R.
    Am J Med; 1989 Apr 17; 86(4A):98-102. PubMed ID: 2523665
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
    Nelson EB, Pool JL, Taylor AA.
    Clin Pharmacol Ther; 1986 Dec 17; 40(6):694-7. PubMed ID: 2946507
    [Abstract] [Full Text] [Related]

  • 14. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ, Holmes DG, Lasance A, de Zwart P.
    Am J Hypertens; 1991 Feb 17; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [Abstract] [Full Text] [Related]

  • 15. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
    Am J Med; 1989 Apr 17; 86(4A):119-23. PubMed ID: 2523646
    [Abstract] [Full Text] [Related]

  • 16. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
    Chrysant SG, Weder AB, McCarron DA, Canossa-Terris M, Cohen JD, Gunter PA, Hamilton BP, Lewin AJ, Mennella RF, Kirkegaard LW, Weir MR, Weinberger MH.
    Am J Hypertens; 2000 Nov 17; 13(11):1180-8. PubMed ID: 11078178
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
    Andersson OK, Persson B, Hedner T, Aurell M, Wysocki M.
    J Hypertens; 1989 Jun 17; 7(6):465-9. PubMed ID: 2528578
    [Abstract] [Full Text] [Related]

  • 18. An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients.
    McMahon FG, Vargas R, Ryan JR, Miller H, Faraday S.
    J Clin Pharmacol; 1988 Jul 17; 28(7):664-6. PubMed ID: 2975291
    [Abstract] [Full Text] [Related]

  • 19. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL, Stegeman CJ, Beekman J, Siegers AM, Hagels G, de Bruijn JH.
    Am J Hypertens; 1991 Feb 17; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M, Petrocelli A, Garofalo M, Celentano A, Alfieri A, de Divitiis O.
    J Int Med Res; 1995 Feb 17; 23(4):234-43. PubMed ID: 7589766
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.